Orally active acridones as novel and potent antimalarial chemotypes

被引:0
|
作者
Kelly, Jane X. [1 ]
Smilkstein, Martin [1 ]
Winter, Rolf [1 ]
Doclean, Rosie [1 ]
Hinrichs, Dave [1 ]
Riscoe, Mike [1 ]
机构
[1] Portland VA Med Ctr, Portland, OR USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
870
引用
收藏
页码:250 / 251
页数:2
相关论文
共 50 条
  • [21] Potent, orally active GABA(B) receptor antagonists
    Froestl, W
    Mickel, SJ
    Schmutz, M
    Bittiger, H
    PHARMACOLOGY: REVIEWS AND COMMUNICATIONS, VOL 8, NOS 2-3, 1996, SPECIAL ISSUE: 3RD INTERNATIONAL GABA(B) SYMPOSIUM, 1996, : 127 - 133
  • [22] ETHYNYL ESTRADIOL - POTENT ORALLY ACTIVE CONTRACEPTIVE IN RATS
    WATNICK, AS
    VINEGRA, M
    GIBSON, J
    TOLKSDORF, S
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1964, 116 (02): : 343 - &
  • [23] Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase
    Li, Xinnan
    Ze, Xiaotong
    Zhou, Shengnan
    Hu, Zhaoxin
    He, Chen
    Jia, Yilin
    Liu, Lihua
    Wang, Tao
    Li, Junda
    Xu, Shengtao
    Yang, Dong-Hua
    Chen, Zhe-Sheng
    Yao, Hequan
    Xu, Jinyi
    Yao, Hong
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 5118 - 5153
  • [24] Identification of a novel boronic acid as a potent, selective, and orally active hormone sensitive lipase inhibitor
    Ogiyama, Tomoko
    Yamaguchi, Mitsuhiro
    Kurikawa, Nobuya
    Honzumi, Shoko
    Yamamoto, Yuka
    Sugiyama, Daisuke
    Inoue, Shinichi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (16) : 3801 - 3807
  • [25] Discovery of novel tetracyclic tetrahydrofuran derivatives as potent, orally active, broad spectrum psychotropic agents
    Alonso, JM
    Andrés, JI
    Cid, JM
    Díaz, A
    Fernández, J
    Iturrino, L
    Gil, P
    Megens, A
    Sipido, VK
    Trabanco, AA
    Proceedings of the Joint Meeting on Medicinal Chemistry, 2005, : 63 - 66
  • [26] Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase
    Mano, T
    Stevens, RW
    Ando, K
    Nakao, K
    Okumura, Y
    Sakakibara, M
    Okumura, T
    Tamura, T
    Miyamoto, K
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (18) : 3879 - 3887
  • [27] Structure-activity relationships of novel, highly potent, selective, and orally active CCRI antagonists
    Xie, Yun Feng
    Lake, Kirk
    Ligsay, Kathleen
    Komandla, Mallareddy
    Sircar, Ila
    Nagarajan, Gobi
    Li, Jian
    Xu, Kui
    Parise, Jason
    Schneider, Lisa
    Huang, Ding
    Liu, Juping
    Dines, Kevin
    Sakurai, Naoki
    Barbosa, Miguel
    Jack, Rick
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3367 - 3372
  • [28] DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUG
    Kanou, M.
    Nishiwaki, Y.
    Nakano, A.
    Yamanaka, Y.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 79 - 79
  • [29] 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors
    Beckers, T
    Reissmann, T
    Schmidt, M
    Burger, AM
    Fiebig, HH
    Vanhoefer, U
    Pongratz, H
    Hufsky, H
    Hockemeyer, J
    Frieser, M
    Mahboobi, S
    CANCER RESEARCH, 2002, 62 (11) : 3113 - 3119
  • [30] Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family
    Posner, GH
    Parker, MH
    Northrop, J
    Elias, JS
    Ploypradith, P
    Xie, SJ
    Shapiro, TA
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) : 300 - 304